SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
MXCT

Maxcyte, Inc. (MXCT)

NASDAQ: MXCT · Real-Time Price · USD
Healthcare · Medical Devices
$1.25+$0.08 (+6.84%)
 
Market cap
$129M
Insider Score
Analyst consensus
Insider Score
80/ 100
MXCT Insider Score
Bullish

1 qualifying trade · 1 insider · $120.78K bought in the last 90 days

MXCT Income Statement

Fiscal PeriodQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025
Revenue$10.15 M$7.27 M$9.65 M$7.30 M$6.83 M
Revenue Growth (YoY)48.66 %————
Cost of Revenue$1.68 M$1.68 M$1.57 M$1.61 M$1.60 M
Gross Profit$8.47 M$5.60 M$8.08 M$5.69 M$5.23 M
SG&A Expense$10.77 M$10.62 M$9.39 M$8.99 M$9.96 M
R&D Expense$2.87 M$4.25 M$3.86 M$3.33 M$5.32 M
Operating Expenses$14.51 M$15.83 M$14.27 M$13.36 M$16.32 M
Operating Income-$6.04 M-$10.23 M-$6.18 M-$7.67 M-$11.09 M
Pretax Income-$4.76 M-$8.87 M-$4.75 M-$9.60 M-$12.42 M
Tax Provision$0.00$0.00$0.00$0.00$0.00
Net Income-$4.76 M-$8.87 M-$4.75 M-$9.60 M-$12.42 M
EPS (Basic)-$0.05-$0.08-$0.04-$0.09-$0.12
EPS (Diluted)-$0.05-$0.08-$0.04-$0.09-$0.12
Shares Outstanding103.54 M106.82 M106.88 M106.73 M106.61 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Maxcyte, Inc. (MXCT) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com